SM
NVO

Sweeney & Michel’s Novo Nordisk NVO Stock Holding History

Sweeney & Michel’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$221K Buy
+1,871
New +$250K 0.09% 110

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sweeney & Michel's NVO Position: Q3 2024 in Review

Sweeney & Michel opened a new position in Novo Nordisk (NVO) in Q3 2024: 1,871 shares worth $221K. The stake represents 0.09% of the portfolio and ranks #110 among its holdings.

1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Sweeney & Michel held 1,871 shares of Novo Nordisk worth $221K as of Q3 2024.
  • Novo Nordisk was a new Sweeney & Michel position in Q3 2024.
  • Novo Nordisk made up 0.09% of Sweeney & Michel's portfolio in Q3 2024, its #110 holding.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Sweeney & Michel's 13F filing for Q3 2024, filed 21 Oct 2024.